Inovio reports early flu vaccine results; Supercomputer Watson donates winnings to malaria research;

> Inovio Pharmaceuticals ($INO) said a Phase I trial of its avian flu vaccine SynCon generated HAI titers against six different strains of H5N1, presenting a possible development path for a universal flu vaccine. Inovio release

> Bionor Pharma's universal influenza vaccine, Vacc-Flu, reduced serious flu symptoms by 25% in an animal study. Bionor release

> The U.S. is reaching out to Australia's Commonwealth Scientific and Industrial Research Organization to help with development of vaccines to combat bioterrorism. Article

> 10 promising therapeutic vaccines to watch. Article

And Finally... IBM, which developed JEOPARDY! champion Watson, is donating half of the supercomputer's $1 million in winnings to Scripp Research Institute to conduct malaria research. Release

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.